Loading…

Does single application of topical chloramphenicol to high risk sutured wounds reduce incidence of wound infection after minor surgery? Prospective randomised placebo controlled double blind trial

Objective To determine the effectiveness of a single application of topical chloramphenicol ointment in preventing wound infection after minor dermatological surgery.Design Prospective randomised placebo controlled double blind multicentre trial.Setting Primary care in a regional centre in Queenslan...

Full description

Saved in:
Bibliographic Details
Published in:BMJ 2009-01, Vol.338 (7688), p.211-214
Main Authors: Heal, Clare F, Buettner, Petra G, Cruickshank, Robert, Graham, David, Browning, Sheldon, Pendergast, Jayne, Drobetz, Herwig, Gluer, Robert, Lisec, Carl
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To determine the effectiveness of a single application of topical chloramphenicol ointment in preventing wound infection after minor dermatological surgery.Design Prospective randomised placebo controlled double blind multicentre trial.Setting Primary care in a regional centre in Queensland, Australia.Participants 972 minor surgery patients.Interventions A single topical dose of chloramphenicol (n=488) or paraffin ointment (n=484; placebo).Main outcome measure Incidence of infection.Results The incidence of infection in the chloramphenicol group (6.6%; 95% confidence interval 4.9 to 8.8) was significantly lower than that in the control group (11.0%; 7.9 to 15.1) (P=0.010). The absolute reduction in infection rate was 4.4%, the relative reduction was 40%, and the relative risk of wound infection in the control group was 1.7 (95% confidence interval 1.1 to 2.5) times higher than in the intervention group. The number needed to treat was 22.8.Conclusion Application of a single dose of topical chloramphenicol to high risk sutured wounds after minor surgery produces a moderate absolute reduction in infection rate that is statistically but not clinically significant.Trial registration Current Controlled Trials ISRCTN73223053.
ISSN:0959-8138
0959-535X
1468-5833
1756-1833
DOI:10.1136/bmj.a2812